Skip to main content

Day: November 6, 2019

Denali Therapeutics Reports Third Quarter 2019 Financial Results and Business Highlights

SOUTH SAN FRANCISCO, Calif., Nov. 06, 2019 (GLOBE NEWSWIRE) — Denali Therapeutics Inc. (NASDAQ: DNLI), a biopharmaceutical company developing a broad portfolio of product candidates for neurodegenerative diseases, today reported financial results for the third quarter ended September 30, 2019, and provided business highlights.“Our clinical and preclinical programs continue to progress and we plan to submit an IND or CTA for two programs by year-end 2019. One of these programs, ETV:IDS, will be our first biotherapeutic engineered to cross the blood-brain barrier using our Transport Vehicle platform. We are also particularly excited about our LRRK2 program and the potential to make a difference for patients suffering from Parkinson’s disease,” said Ryan Watts, Ph.D., CEO.Third Quarter 2019 and Recent Business HighlightsFirst...

Continue reading

Sutter Rock Capital Corp. Reports Third Quarter 2019 Financial Results

Net Asset Value of $11.24 Per Share as of September 30, 2019Sutter Rock Declares $0.20 Per Share DividendSAN FRANCISCO, Nov. 06, 2019 (GLOBE NEWSWIRE) — Sutter Rock Capital Corp. (“Sutter Rock” or the “Company”) (Nasdaq:SSSS) today announced financial results for the quarter ended September 30, 2019.  Net assets totaled approximately $213.9 million, or $11.24 per share, at September 30, 2019, as compared to $9.89 per share at December 31, 2018 and $10.58 per share at September 30, 2018.  On November 5, 2019, Sutter Rock’s Board of Directors declared a dividend in the amount of $0.20 per share payable on December 12, 2019 to the Company’s common stockholders of record as of the close of business on December 2, 2019.“We are pleased to announce that our Board of Directors has declared a dividend in the amount of $0.20 per share,” said...

Continue reading

Kane Biotech Announces Date of Q3 Earnings Release

WINNIPEG, Manitoba, Nov. 06, 2019 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX-V:KNE), (the “Corporation” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms, today announced that they will release third quarter fiscal 2019 earnings on Thursday, November 14 after market close.The Q3 earnings release will be available on Kane’s investor site at https://ir.kanebiotech.com/press-releases.About Kane BiotechKane Biotech is a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Corporation has a portfolio of biotechnologies, intellectual property (56 patents and patents pending, trade secrets and trademarks) and products...

Continue reading

Gladstone Land Announces Third Quarter 2019 Results

Please note that the limited information that follows in this press release is a summary and is not adequate for making an informed investment judgment.MCLEAN, Va., Nov. 06, 2019 (GLOBE NEWSWIRE) — Gladstone Land Corporation (Nasdaq: LAND) (“Gladstone Land” or the “Company”) today reported financial results for the third quarter ended September 30, 2019.  A description of funds from operations (“FFO”), core FFO (“CFFO”), adjusted FFO (“AFFO”), and net asset value (“NAV”), all non-GAAP (generally accepted accounting principles in the United States) financial measures, is located at the end of this press release.  All per-share references are to fully-diluted, weighted-average shares of the Company’s common stock unless noted otherwise.  For further detail, please refer to the Company’s Quarterly Report on Form 10-Q (the “Form 10-Q”),...

Continue reading

PDC Energy Announces 2019 Third Quarter Financial and Operating Results

DENVER, Nov. 06, 2019 (GLOBE NEWSWIRE) — PDC Energy, Inc. (“PDC”, “Company”, “we” or “us”) (NASDAQ: PDCE) today reported its 2019 third quarter financial and operating results.   Third Quarter 2019 Highlights:Net cash from operating activities of $234 million, adjusted cash flow from operations, a non-U.S. GAAP financial measure defined below, of approximately $202 million, and oil and gas capital investments of $164 million.Approximately $39 million of free cash flow, a non-U.S. GAAP measure defined as net cash from operating activities, adjusted for changes in working capital, less oil and gas capital investments.Total production of 12.7 million barrels of oil equivalent (“MMBoe”), or approximately 138,000 Boe per day, a 26 percent increase from the third quarter of 2018.Lease operating expenses (“LOE”)...

Continue reading

Uniti Group Inc. Declares $0.22 Per Share Quarterly Dividend

LITTLE ROCK, Ark., Nov. 06, 2019 (GLOBE NEWSWIRE) — Uniti Group Inc. (“Uniti”) (Nasdaq: UNIT) announced that its Board of Directors declared a quarterly cash dividend yesterday of $0.22 per share, payable on January 15, 2020 to stockholders of record on December 31, 2019.ABOUT UNITIUniti, an internally managed real estate investment trust, is engaged in the acquisition and construction of mission critical communications infrastructure, and is a leading provider of wireless infrastructure solutions for the communications industry.  As of June 30, 2019, Uniti owns 5.6 million fiber strand miles, approximately 570 wireless towers, and other communications real estate throughout the United States. Additional information about Uniti can be found on its website at www.uniti.com.INVESTOR AND MEDIA CONTACTS:Mark A. Wallace, 501-850-0866Executive...

Continue reading

Stifel Declares Quarterly Common Stock Cash Dividend and Declares Preferred Stock Cash Dividend

ST. LOUIS, Nov. 06, 2019 (GLOBE NEWSWIRE) — Stifel Financial Corp. (NYSE: SF) today announced that its Board of Directors has declared a cash dividend on shares of its common stock of $0.15 per share, payable December 16, 2019, to shareholders of record at the close of business on December 2, 2019.The Board of Directors also declared a quarterly cash dividend on the outstanding shares of its 6.25% Non-Cumulative Perpetual Preferred Stock, Series A (the “Series A Preferred Stock”) and 6.25% Non-Cumulative Perpetual Preferred Stock, Series B (the “Series B Preferred Stock”). The declared cash dividend on the Series A Preferred Stock and the Series B Preferred Stock is for the period from September 15, 2019, up to, but excluding December 15, 2019.  The declared cash dividend equated to approximately $0.390625 per depositary share,...

Continue reading

Armada Hoffler Properties Announces Quarterly Dividends

VIRGINIA BEACH, Va., Nov. 06, 2019 (GLOBE NEWSWIRE) — Armada Hoffler Properties, Inc. (NYSE: AHH) announced that its Board of Directors declared a cash dividend of $0.21 per common share for the fourth quarter of 2019. The fourth quarter dividend will be paid in cash on January 2, 2020 to stockholders of record on December 23, 2019.The Board of Directors also declared a cash dividend of $0.421875 per share on its 6.75% Series A Cumulative Redeemable Perpetual Preferred Stock payable on January 15, 2020, to stockholders of record on January 2, 2020.About Armada Hoffler Properties, Inc.Armada Hoffler Properties, Inc. (NYSE: AHH) is a vertically-integrated, self-managed real estate investment trust (“REIT”) with four decades of experience developing, building, acquiring, and managing high-quality, institutional-grade office,...

Continue reading

National Bank Holdings Corporation Announces 5.3% Increase in Quarterly Dividend

DENVER, Colo., Nov. 06, 2019 (GLOBE NEWSWIRE) — National Bank Holdings Corporation (NYSE: NBHC) announced today that its Board of Directors approved a cash dividend to shareholders. The quarterly cash dividend will increase 5.3% from nineteen cents ($0.19) to twenty cents ($0.20) per share of common stock. The dividend will be payable on December 13, 2019 to shareholders of record at the close of business on November 29, 2019.“We are very pleased to be delivering an 18% increase in our dividend over the last twelve months. Our earnings growth and strong capital position continue to translate into attractive returns for our shareholders,” said Chairman and CEO, Tim Laney.About National Bank Holdings CorporationNational Bank Holdings Corporation is a bank holding company created to build a leading community bank franchise delivering...

Continue reading

OraSure Technologies, Inc. Announces Purchase of Diversigen

BETHLEHEM, Pa., Nov. 06, 2019 (GLOBE NEWSWIRE) — OraSure Technologies, Inc. (NASDAQ: OSUR), a leader in point of care diagnostic tests and specimen collection and stabilization devices, today announced that it has entered into a definitive agreement to acquire the outstanding equity of Diversigen in an all-cash transaction.Diversigen is a privately held microbiome industry pioneer based in Houston, Texas. Diversigen provides science-driven, customized solutions for metagenomics sequencing, bioinformatics, and statistical analysis for the study of the microbiome.  The company was founded in 2013 by Dr. Joseph Petrosino, director of the Alkek Center for Metagenomics and Microbiome Research at the Baylor College of Medicine (BCM), where Diversigen is a BCM portfolio company.As the first company to establish microbiome protocols in...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.